HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

BORBA Enters Mass With Aspirations To Be "Synonymous With Innovation"

This article was originally published in The Rose Sheet

Executive Summary

California-based “beautyceutical” marketer BORBA plans to broaden its customer base with the national debut of a new line exclusively at Walgreens, representing the brand’s first foray into the mass-market channel.

You may also be interested in...



Attorney: FTC Put Industry “On Notice” With Nivea Case

When the Federal Trade Commission seized upon Beiersdorf’s 2011 claims that Nivea My Silhouette! skin cream could substantially reduce consumers’ body size, it served as a reminder that the commission keeps an eye on personal-care claims, especially when they veer into the weight loss arena, according to attorney Richard Jacobson.

High Expectations For Energy Drink Actives, Bee Venom In Skin Care

The skin-care ingredients space is crowded with options, but beauty executives at HBA Global Expo in New York project that some outside-of-the-box actives will be the next big thing.

More Consumers Follow Green Instincts In Health-Care Product Choices

More mainstream consumers want health-care products to not only be safe and effective, but also “clean,” sustainable and “soulful,” says Hartman Group researcher Greg Prang. A connection between natural and health care sprang from the green movement, which positioned organic as healthier than manmade.

Related Content

UsernamePublicRestriction

Register

RS017413

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel